Filing Details

Accession Number:
0001610717-23-000234
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-23 18:31:54
Reporting Period:
2023-08-21
Accepted Time:
2023-08-23 18:31:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1676725 Ideaya Biosciences Inc. IDYA Pharmaceutical Preparations (2834) 474268251
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1777511 A. Paul Stone C/O Ideaya Biosciences, Inc.
7000 Shoreline Court, Suite 350
South San Francisco CA 94080
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-08-21 978 $26.40 14,303 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 27, 2023.
  2. This transaction was executed in multiple trades in prices ranging from $26.38 to $26.4175, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.